Who is sponsoring NCT04273113?

NCT04273113 is sponsored by University of Birmingham.

What condition does NCT04273113 study?

NCT04273113 studies Emotional Dysfunction.

Is NCT04273113 still recruiting?

NCT04273113 is currently status unknown. Last updated 17 February 2020.

Last reviewed 2020-02-17 · How we verify

NCT04273113

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Does Heart Rate Variance (HRV) Biofeedback Help Regulate Emotions and Improve Mindfulness in Mentally Unwell Offenders?

Status unknown NA Last updated 17 February 2020

What this trial tests

NA trial testing Difficulties in Emotional Regulation Scale, Five Facet Mindfulness Questionnaire, Becks Depression and Becks Anxiety in Emotional Dysfunction in 14 participants. Status unknown.

Timeline

11 October 2017

Primary endpoint
27 April 2018

28 March 2020

Quick facts

Lead sponsor	University of Birmingham
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	11 October 2017
Primary completion	27 April 2018
Estimated completion	28 March 2020
Sites	1 location across United Kingdom

Drugs / interventions tested

Difficulties in Emotional Regulation Scale, Five Facet Mindfulness Questionnaire, Becks Depression and Becks Anxiety
HRV Biofeedback (Healing Rhythms)

Conditions studied

Emotional Dysfunction — all drugs for Emotional Dysfunction →

Sponsor

University of Birmingham

Who can join

Adults 18 to 77, any sex, with Emotional Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

14 participants residing in a forensic psychiatric hospital completed 15 Heart Rate Variance (HRV) biofeedback sessions. They completed 4 psychometric questionnaires, pre, during and post biofeedback training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Emotional Dysfunction

Currently open trials in the same condition.

NCT05712057 — Neurostimulation Versus Therapy for Problems With Emotions · NA · recruiting
NCT05930886 — Focus Groups in Ethnically and Racially Diverse Families · recruiting

Other University of Birmingham trials

Trials by the same sponsor.

NCT07160686 — Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment · Phase 3 · not yet recruiting
NCT07446166 — TETANUS Antibody Detection in Saliva Study · NA · not yet recruiting
NCT07294794 — Personalised Pharmacometabolomic-guided Strategy Trial to Optimise Treatment for Hypertension · NA · not yet recruiting
NCT07246356 — Feasibility and Efficacy of GTEP for Birth Trauma · NA · recruiting
NCT06932653 — Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04273113 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Birmingham
Last refreshed: 17 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04273113.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing